Pennant Reports Fourth Quarter and Fiscal Year 2023 Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Financial and Business Highlights
The gain on bargain purchase from the Sprint acquisition was $254.0 million for Q4 2023 and was $1.4 billion for full year 2023.Included in the gain on bargain.
RANCHO CUCAMONGA - Amphastar Pharmaceuticals, Inc. today reported results for the three months and full-year ended December 31, 2023.
Fourth Quarter Highlights
Net revenues of $178.1 million for.
GENFIT Announces Revenues and Cash Position as of December 31, 2023 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.